2003 Gordon Conference on Proteins

描述（由申请人提供）：“蛋白质”戈登研究会议是一年两次的会议，具有悠久而杰出的历史。会议旨在汇集积极参与蛋白质结构和功能的生物化学和生物物理学研究的研究人员。在选择演讲者和主题时，我们征求了整个蛋白质科学界的意见。许多建议被纳入我们的最终计划。里根教授是2001年蛋白质会议的联合主席，克莱维特教授是演讲者。这次会议以讨论的范围和深度而闻名，最重要的是，很大一部分与会者积极参与。我们打算在这方面仿效2001年的会议，此外，通过从海报会议中挑选几位发言者口头介绍其工作，加强参与。根据以往的会议，科学界的投入，最近的进展和发现，以及潜在发言者的质量，我们选择的具体重点领域是： 1)膜蛋白的结构和功能 2)蛋白质作为治疗剂和药物靶点 3)疾病中的蛋白质 4)新结构和新方法 5)蛋白-蛋白相互作用 6)单分子和蛋白质机器 7)蛋白质折叠和稳定性 8)展开状态 会议激发的研究应该直接有利于生物医学研究在相当广泛的领域的进展。最后，组织者特别注意确保妇女和少数群体在这次会议上的充分代表性。

DESCRIPTION (provided by applicant): The "Proteins" Gordon Research Conference is a biannual conference with a long and distinguished history. The conference aims to bring together researchers who are actively involved in research into the biochemistry and biophysics of protein structure and function. In choosing speakers and topics, we solicited input from across the protein science community. Many suggestions are incorporated into our final program. Professor Regan was co-chair of the 2001 Proteins conference and Professor Klevit was a speaker. This conference was notable for the range and depth of discussion and, most importantly, for the active participation of a large fraction of the attendees. We aim to emulate the 2001 meeting in this regard and, in addition, to enhance participation by choosing a few speakers from the poster sessions to present their work orally. The specific areas of focus we have chosen, based upon previous conferences, input from the scientific community, recent progress and discoveries, and quality of potential speakers are: 1) Structure and function of membrane proteins 2) Proteins as therapeutics and drug targets 3) Proteins in disease 4) New structures and new methods 5) Protein-protein interactions 6) Single molecules and protein machines 7) Protein folding and stability 8) The unfolded state The research stimulated by the conference should directly benefit the progress of biomedical research across a fairly broad field. Finally, the organizers are particularly sensitive to ensuring the full representation of women and minorities in this meeting.